(thirdQuint)Clinical Study of Passeo-18 Lux Balloon Catheter for the Treatment of Atherosclerotic Lesions(BIOLUX-P IV CHINA).

 A prospective, multi-centre, non-randomized clinical trial with follow-up investigations at 1, 6 and 12 months.

 Approximately 250 subjects will be enrolled at 15 Chinese study sites.

 To confirm the safety and efficacy of the Passeo-18 Lux DCB for the interventional treatment of new and non-stented re-stenotic lesions in the superficial femoral artery (SFA) and proximal popliteal artery (PPA) in a Chinese patient population.

.

 Clinical Study of Passeo-18 Lux Balloon Catheter for the Treatment of Atherosclerotic Lesions(BIOLUX-P IV CHINA)@highlight

Prospective, multi-center, non-randomized clinical trial with follow-up investigations at 1, 6 and 12 months.

 To confirm safety and efficacy of Passeo-18 Lux DCB in new and non-stented re-stenotic lesions in the superficial femoral artery (SFA) and proximal popliteal artery (PPA) in a Chinese patient population.

